Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.52 |
| ▸ | RRM1 | P23921 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 7/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28837099 | 0.86 | DPP7 (0.47) | DPP7RRM1USP2GNAI3GNAO1 | |
| SCHEMBL15007034 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL15007071 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL15006955 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL25334168 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL25334804 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL10481744 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL3758969 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL15007014 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL15006734 | 0.84 | GNAI3 (0.58) | DPP7RRM1EPHX1GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003103653-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES | ELAN PHARMACEUTICALS, INC. (US) | 2003-12-18 | — | — | WO | disclosed |